An RF engineer explains why packet loss, multipath interference, and battery tradeoffs are scientific validity issues, not IT problems.
- Why Ophthalmology Trials Are Clinical Research's Toughest Tech Test
- Why Trustworthy Clinical Trial Data Starts As Analog, Not Digital
- Why Clinical Trial Coordinators Are Still The Human API
- The Cost And ROI Of Agentic AI In Clinical Trials: What Sponsors And CROs Need To Know
- Designing eCOA Technology Patients Can Actually Use
- Clinical Trial Technology Doesn't Fail – It Fails At The Handoff
- Why Life Science Tech Pilots Fail After The Demo — And How To Avoid It
- Inside Versiti's Data Strategy: Building AI-Ready Research Systems
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
RBQM For Decentralized Trials: Two Key Areas Of Focus To Reduce Your Risk
This article takes a more in-depth look at Sections 5.0.5: ‘Risk Communication’ and 5.0.6: ‘Risk Review.’ in ICH-GCP E6 R2 to show how the implementation of RBQM can reduce issues and achieve holistic trial oversight in today’s complex decentralized trials.
-
The Vendor Selection Blunder: An Expensive Oversight In Clinical Trials
Vendor selection isn’t just procedural — it shapes trial outcomes. Even with a solid process, missteps can ripple through timelines, budgets, and team morale. Choose wisely.
-
Data Quality And Monitoring In Clinical Trials: Reducing Errors And Ensuring Compliance
Clear data ownership and tailored reporting tools reduce errors and manual reconciliation, keeping trial data accurate and audit-ready.
-
Your CRAs Aren't Monitoring. They're Managing Workarounds.
CRA productivity rises when monitoring shifts from manual tasks to streamlined access, standardized workflows, and proactive oversight — freeing time for engagement, data quality, and patient safety.
-
Oncology Preferences From Patients And Caregivers On Trial Tech
Delve into the preferences of patients and caregivers in the field of oncology, specifically regarding eConsent, telehealth, wearables, and other digital technologies.
-
What Universalized Terminology Means For Decentralized Research
Many DCT stakeholders have attempted to release terminology guides as it relates to their own dealings, however, there had never been a wide range of universalized DCT terms until now.
-
Own Your Data, Accelerate Your Cure
Move from passive donor to active innovator. Explore how patient communities are building their own research infrastructure and using AI to bypass traditional barriers to drug development.
-
Bringing Clinical Research To The Patient Using Patient-Centric Tech
By fostering daily interactions between patients and technology, these smart hubs offer a sustainable approach to ensuring the success and integrity of clinical trials in an evolving landscape of drug development.
-
Fujirebio Increases Study Agility By Streamlining Clinical Operations And Data Management Process
Fujirebio’s fast-growing U.S. Clinical R&D team was preparing for shorter studies with higher complexity. Traditional methods using paper and spreadsheet trackers were no longer adequate to meet quality goals. Learn how the group increased its agility and readiness with LifeSphere Clinical EDC and CTMS tools.
- Wireless Connectivity Is A Data Integrity Issue, Not IT
- Why Clinical AI Validation Needs Portability Testing Beyond A Single Accuracy Score
- The Synchronization Problem Clinical Research Isn't Watching
- Why Ophthalmology Trials Are Clinical Research's Toughest Tech Test
- Why Trustworthy Clinical Trial Data Starts As Analog, Not Digital
RECENT NEWSLETTERS
- 08.06.26 -- Clinical Trial Tech: AI, Data Quality, And Faster Study Build
- 08.01.26 -- July's Top Clinical Trial Tech Reads
- 07.30.26 -- Clinical Tech Leadership: Site Burden, AI ROI, And Smarter Trial Tech
- 07.23.26 -- AI, Data Costs, And The Real Barriers To Trial Execution
- 07.16.26 -- Why Clinical Trial Sites Are Drowning In Tech Chaos